Samuel D. Colella, Director, 10% Owner at Flexion Therapeutics Inc (FLXN), bought 10,000 shares at $17.01 ($170K) on 2017-06-05, disclosed to the SEC on 2017-06-06.
Open-market purchase of $170k FLXN by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $17.01 | 5,000 | $85K | 50.0% |
| 2 | $17.01 | 5,000 | $85K | 50.0% |
| Total | $17.01 avg | 10,000 | $170K | 100% |
| Filing → |
| FLDM | BUY | 2019-08-12 | $7K | — | Filing → |
| FLXN | BUY | 2019-08-09 | $21K | — | Filing → |
| FLDM | BUY | 2019-08-08 | $63K | — | Filing → |